Can a simple drug make Weight-Loss surgery safer for heavier patients?
NCT ID NCT07192640
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving tranexamic acid (TXA) through a vein during weight-loss surgery can reduce blood loss in patients with a very high body mass index (BMI over 45). About 128 high-risk adults will receive TXA or a placebo to see if it lowers the need for blood transfusions and prevents complications. The goal is to make bariatric surgery safer for people with obesity and related health issues like diabetes or heart disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
King Salman Specialist Hospital, Hail, KSA
Ha'il, 6539307, Saudi Arabia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A cup of lavender tea a day may keep PMS blues away — science puts it to the test
- New pill KDS2010 aims to shed pounds in obesity trial
- New sponge stops bleeding faster after wisdom tooth extraction
- Obesity blocks kidney transplants: new study investigates why
- New toothpaste fights gum disease in 12-Week trial
- Could LVAD patients ditch aspirin? new trial aims to find out